These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16366601)

  • 1. Novel indole-based peroxisome proliferator-activated receptor agonists: design, SAR, structural biology, and biological activities.
    Mahindroo N; Huang CF; Peng YH; Wang CC; Liao CC; Lien TW; Chittimalla SK; Huang WJ; Chai CH; Prakash E; Chen CP; Hsu TA; Peng CH; Lu IL; Lee LH; Chang YW; Chen WC; Chou YC; Chen CT; Goparaju CM; Chen YS; Lan SJ; Yu MC; Chen X; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2005 Dec; 48(26):8194-208. PubMed ID: 16366601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies.
    Mahindroo N; Wang CC; Liao CC; Huang CF; Lu IL; Lien TW; Peng YH; Huang WJ; Lin YT; Hsu MC; Lin CH; Tsai CH; Hsu JT; Chen X; Lyu PC; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2006 Feb; 49(3):1212-6. PubMed ID: 16451087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists.
    Mahindroo N; Peng YH; Lin CH; Tan UK; Prakash E; Lien TW; Lu IL; Lee HJ; Hsu JT; Chen X; Liao CC; Lyu PC; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2006 Oct; 49(21):6421-4. PubMed ID: 17034149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation.
    Wei ZL; Petukhov PA; Bizik F; Teixeira JC; Mercola M; Volpe EA; Glazer RI; Willson TM; Kozikowski AP
    J Am Chem Soc; 2004 Dec; 126(51):16714-5. PubMed ID: 15612696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.
    Lu IL; Huang CF; Peng YH; Lin YT; Hsieh HP; Chen CT; Lien TW; Lee HJ; Mahindroo N; Prakash E; Yueh A; Chen HY; Goparaju CM; Chen X; Liao CC; Chao YS; Hsu JT; Wu SY
    J Med Chem; 2006 May; 49(9):2703-12. PubMed ID: 16640330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAR-oriented discovery of peroxisome proliferator-activated receptor pan agonist with a 4-adamantylphenyl group as a hydrophobic tail.
    Kasuga J; Yamasaki D; Ogura K; Shimizu M; Sato M; Makishima M; Doi T; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1110-5. PubMed ID: 18162399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis.
    Hopkins CR; O'neil SV; Laufersweiler MC; Wang Y; Pokross M; Mekel M; Evdokimov A; Walter R; Kontoyianni M; Petrey ME; Sabatakos G; Roesgen JT; Richardson E; Demuth TP
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5659-63. PubMed ID: 16919947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.
    Epple R; Cow C; Xie Y; Azimioara M; Russo R; Wang X; Wityak J; Karanewsky DS; Tuntland T; Nguyêñ-Trân VT; Cuc Ngo C; Huang D; Saez E; Spalding T; Gerken A; Iskandar M; Seidel HM; Tian SS
    J Med Chem; 2010 Jan; 53(1):77-105. PubMed ID: 19928766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists.
    Peng YH; Coumar MS; Leou JS; Wu JS; Shiao HY; Lin CH; Lin WH; Lien TW; Chen X; Hsu JT; Chao YS; Huang CF; Lyu PC; Hsieh HP; Wu SY
    ChemMedChem; 2010 Oct; 5(10):1707-16. PubMed ID: 20734309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of novel constrained meta-substituted phenyl propanoic acids as peroxisome proliferator-activated receptor alpha and gamma dual agonists.
    Suh YG; Kim NJ; Koo BW; Lee KO; Moon SH; Shin DH; Jung JW; Paek SM; Chang DJ; Li F; Kang HJ; Le TV; Chae YN; Shin CY; Kim MK; Lim JI; Ryu JS; Park HJ
    J Med Chem; 2008 Oct; 51(20):6318-33. PubMed ID: 18826205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships and key structural feature of pyridyloxybenzene-acylsulfonamides as new, potent, and selective peroxisome proliferator-activated receptor (PPAR) γ Agonists.
    Rikimaru K; Wakabayashi T; Abe H; Tawaraishi T; Imoto H; Yonemori J; Hirose H; Murase K; Matsuo T; Matsumoto M; Nomura C; Tsuge H; Arimura N; Kawakami K; Sakamoto J; Funami M; Mol CD; Snell GP; Bragstad KA; Sang BC; Dougan DR; Tanaka T; Katayama N; Horiguchi Y; Momose Y
    Bioorg Med Chem; 2012 May; 20(10):3332-58. PubMed ID: 22503460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists.
    Filzen GF; Bratton L; Cheng XM; Erasga N; Geyer A; Lee C; Lu G; Pulaski J; Sorenson RJ; Unangst PC; Trivedi BK; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3630-5. PubMed ID: 17512197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists.
    Liu Q; Zhang YY; Lu HL; Li QY; Zhou CH; Wang MW
    Acta Pharmacol Sin; 2007 Dec; 28(12):2033-9. PubMed ID: 18031620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Design, synthesis and insulin-sensitizing activity of indole derivatives].
    Tang L; Yang YS; Ji RY
    Yao Xue Xue Bao; 2006 Mar; 41(3):225-9. PubMed ID: 16758992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARgamma ligands (I).
    Dong X; Zhang Z; Wen R; Shen J; Shen X; Jiang H
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5913-6. PubMed ID: 17010604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein.
    Castriota G; Thompson GM; Lin Y; Scherer PE; Moller DE; Berger JP
    Cell Biol Int; 2007 Jun; 31(6):586-91. PubMed ID: 17240171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
    Moyers JS; Shiyanova TL; Mehrbod F; Dunbar JD; Noblitt TW; Otto KA; Reifel-Miller A; Kharitonenkov A
    J Cell Physiol; 2007 Jan; 210(1):1-6. PubMed ID: 17063460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.